Beyond Air
XAIR | NASDAQ
$2.02
-$0.11 (-5.16%)
At close: Nov 16, 2026, 4:00 PM ET
$1.92
-$0.10 (-4.95%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-5.16%
(1D)No price chart data available for 1D timeframe.
Rating
44.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #398/1021 (Top 39%)
Key Statistics
Market Data
Market Cap $1.28M
1D Range
1.90 2.10
52W Range
1.90 43.80
Valuation (TTM)
PE -0.06
PB 0.24
EV/EBITDA -0.47
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $10.00
Cash Flow
FCF Yield -1655.2%
SBC Adj. FCF Yield -1919.8%
SBC Impact -16.0%
Margins
Gross Margin 10.0%
Operating Margin -321.6%
FCF Margin -259.0%
Growth (CAGR)
Revenue 3Y | 5Y 201.8% |
94.5%
Dil EPS 3Y | 5Y 106.7% |
44.0%
FCF 3Y | 5Y 49.7% |
13.1%
Returns
ROA -92.0%
ROE -619.1%
ROIC -90.0%
Financial Health
Net Debt
$10.99M
Current Ratio 3.67
Interest Coverage -14.57
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Beyond Air, Inc. functions as a specialized entity involved in both the development of medical devices and biopharmaceutical solutions. A central part of its operations is the LungFit platform, an inn...
Sector Healthcare
Industry Medical - Devices
Employees 54
IPO Date Jun 12, 2018
Website www.beyondair.net
Fiscal Year April - March
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 11, 2026
EPS
-$3.76
Miss -13.60%
YoY:
+84.96% REV
$2.32M
Beat +7.44%
YoY:
+27.83%Next Earnings
Feb 11, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$10.00
Upside
+395.05%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove XAIR